86 related articles for article (PubMed ID: 10851076)
1. Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patients.
Carayol G; Giron-Michel J; Azzarone B; Castagna L; Cambier N; Mishal Z; Bourhis JH; Chouaib S; Caignard A
Oncogene; 2000 May; 19(23):2758-66. PubMed ID: 10851076
[TBL] [Abstract][Full Text] [Related]
2. Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.
Giron-Michel J; Fogli M; Gaggero A; Ferrini S; Caignard A; Brouty-Boye D; Baouz S; Le Bousse-Kerdiles MC; Peault B; van Dijk M; Bulfone-Paus S; Durali D; Chouaib S; Azzarone B
J Exp Med; 2003 Mar; 197(6):763-75. PubMed ID: 12642604
[TBL] [Abstract][Full Text] [Related]
3. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
[TBL] [Abstract][Full Text] [Related]
4. Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15.
Haraguchi K; Suzuki T; Koyama N; Kumano K; Nakahara F; Matsumoto A; Yokoyama Y; Sakata-Yanagimoto M; Masuda S; Takahashi T; Kamijo A; Takahashi K; Takanashi M; Okuyama Y; Yasutomo K; Sakano S; Yagita H; Kurokawa M; Ogawa S; Chiba S
J Immunol; 2009 May; 182(10):6168-78. PubMed ID: 19414770
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia modifies proliferation and differentiation of CD34(+) CML cells.
Desplat V; Faucher JL; Mahon FX; Dello Sbarba P; Praloran V; Ivanovic Z
Stem Cells; 2002; 20(4):347-54. PubMed ID: 12110704
[TBL] [Abstract][Full Text] [Related]
6. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
7. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
[TBL] [Abstract][Full Text] [Related]
8. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
9. Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.
Dylla SJ; Deyle DR; Theunissen K; Padurean AM; Verfaillie CM
Exp Hematol; 2004 Apr; 32(4):365-74. PubMed ID: 15050747
[TBL] [Abstract][Full Text] [Related]
10. Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors.
Giron-Michel J; Giuliani M; Fogli M; Brouty-Boyé D; Ferrini S; Baychelier F; Eid P; Lebousse-Kerdilès C; Durali D; Biassoni R; Charpentier B; Vasquez A; Chouaib S; Caignard A; Moretta L; Azzarone B
Blood; 2005 Oct; 106(7):2302-10. PubMed ID: 15976182
[TBL] [Abstract][Full Text] [Related]
11. Presence of a p70 IL-2-binding peptide on leukemic cells from various hemopoietic lineages.
Allouche M; Sahraoui Y; Augery-Bourget Y; Ohashi Y; Sugamura K; Jasmin C; Georgoulias V
J Immunol; 1989 Oct; 143(7):2223-9. PubMed ID: 2789258
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
13. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
14. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ
Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
Moldenhauer A; Nociari M; Lam G; Salama A; Rafii S; Moore MA
Stem Cells; 2004; 22(2):144-57. PubMed ID: 14990854
[TBL] [Abstract][Full Text] [Related]
16. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
17. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
19. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
Sun R; Li AL; Wei HM; Tian ZG
Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
[TBL] [Abstract][Full Text] [Related]
20. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C
Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
